Expression of Wnt4 in human pituitary adenomas regulates activation of the beta-catenin-independent pathway

Area of Science:

• Endocrinology and Oncology
• Molecular Biology
• Cell Signaling Pathways

Background:

• The Wnt signaling pathway is implicated in various human cancers.
• Wnt4 influences pituitary cell proliferation during embryonic development.
• The role of Wnt signaling in human pituitary adenomas requires elucidation.

Purpose of the Study:

• To investigate the expression of Wnt4 and its receptor Frizzled6 (Fzd6) in human pituitary adenomas.
• To explore the involvement of the Wnt/beta-catenin pathway in pituitary adenoma pathogenesis.
• To determine the signaling mechanisms underlying pituitary adenoma cell proliferation and survival.

Main Methods:

• Immunohistochemistry was used to examine Wnt4 and Fzd6 expression in pituitary adenomas and normal pituitary tissues.
• Beta-catenin localization was assessed to evaluate canonical Wnt pathway activation.
• Erk1/2 activation was analyzed in different adenoma subtypes.

Main Results:

• Wnt4 expression was elevated in growth hormone-, prolactin-, and thyroid-stimulating hormone-producing adenomas compared to normal pituitary.
• Fzd6 was broadly expressed across various pituitary adenoma subtypes.
• Beta-catenin localized to the cell membrane, not the nucleus, in all adenomas; Erk1/2 activation was observed in GHomas and TSHomas.

Conclusions:

• Wnt4/Fzd6 signaling, potentially via a beta-catenin-independent pathway, contributes to pituitary adenoma cell proliferation and survival.
• Further investigation into transcription factors like Pit-1 is warranted.
• This study highlights a novel therapeutic target for pituitary adenomas.